Eli Lilly and Company is monitoring SEC rulemaking and guidance related to the tokenization of securities. At this time, Lilly objects to the inclusion of its securities on any tokenized securities venue (TSV). Any TSV seeking to tokenize Lilly securities, and any related communications, should be directed to the Office of the Corporate Secretary shareholderproposals@lilly.com.  This objection does not express a position on tokenization generally and does not preclude the Company from evaluating further opportunities in the future.